Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GW Receives up to $14.6M to Develop Method for Characterizing Security Threats

Published: Wednesday, January 29, 2014
Last Updated: Monday, February 03, 2014
Bookmark and Share
The researchers are tasked with reducing to 30 days a process that can sometimes take years or even decades.

A team led by a George Washington University (GW) researcher will receive up to $14.6 million over five years from the Defense Advanced Research Projects Agency (DARPA) to develop an approach to rapidly identify the root of biological and chemical threats. If successful, the approach could bolster national security efforts to combat these threats.

“Clearly, this is a very large challenge, and it’s easy to understand why it’s important to overcome,” said Akos Vertes, George Washington University professor of chemistry in the Columbian College of Arts and Sciences. “Discovering the cause behind a biological or chemical threat can provide information that not only counteracts the threat but also provides important information for pharmaceutical companies developing drugs that may be unrelated to the threat.”

Biological threats, such as anthrax, derive from bacteria, while others derive from viruses, toxins or fungi.  Chemical threats include substances that work to interfere with the nervous system or even cause asphyxiation. These threats have the potential to cause widespread, rapid injury or death.

To determine how a biological or chemical threat disrupts life functions, researchers must take a holistic view of the threat and the system in which it is working. The team will examine the effects of toxic agents on genes, proteins and cellular functions using the scientific disciplines of transcriptomics, proteomics, metabolomics and bioinformatics to meet the 30-day challenge. By combining an immense amount of data gleaned from these disciplines, researchers believe it will be easier to determine the workings of a given biological or chemical threat in a given environment.

One problem in achieving this, though, is the fact that the field of metabolomics isn’t as well-developed as other scientific disciplines. However, Dr. Vertes and his team at GW recently developed the Laser Ablation Electrospray Ionization (LAESI) technique, which allows researchers to more quickly and effectively learn the chemical composition of a biological sample. The technique was licensed to Protea Biosciences Inc., which developed the commercial product— the LAESI-DP 1000 Direct Ionization System—last year.

GE Global Research, Protea Biosciences Inc., and SRI International will collaborate with GW on this project, titled, “New Tools for Comparative Systems Biology of Threat Agent Action Mechanisms.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GW Center for Neglected Tropical Diseases to Create Gene Drive to Eliminate Schistosomiasis
GW’s Paul Brindley will work with MIT’s Kevin Esvelt to manipulate the genomes of schistosomiasis-causing parasites, aiming for the eventual elimination of these worms.
Thursday, February 04, 2016
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Wednesday, August 26, 2015
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!